University of California Los Angeles (UCLA) (Adults and Pediatrics) — Los Angeles, California

Public research footprint of University of California Los Angeles (UCLA) (Adults and Pediatrics), compiled from the ClinicalTrials.gov public registry.

166

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B Cell Lymphoma (DLBCL) · Metastatic Cancer · Solid Tumor · Non-Hodgkin Lymphoma Refractory/ Relapsed

Recently updated registry entries

NCT06084936 — A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in… (Recruiting)
NCT07210723 — A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic… (Recruiting)
NCT06563895 — Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California Los Angeles (UCLA) (Adults and Pediatrics)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.